NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
1 hedge funds and large institutions have $27.2K invested in NEVRO CORP. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 125 closing their positions.
99% less funds holding
Funds holding: 126 → 1 (-125)
100% less capital invested
Capital invested by funds: $199M → $27.2K (-$199M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 125
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$22M |
| 2 |
BlackRock
New York
|
-$17.1M |
| 3 |
Goldman Sachs
New York
|
-$12.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.1M |
| 5 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
-$10.8M |
NVRO Hedge Fund Activity: Q2 2025 in Review
1 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2025, worth a combined $27.2K — down 100% from $199M a quarter earlier.
Sellers outnumbered buyers: 125 funds closed out of NVRO and 0 opened new positions — a net loss of 125 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Osaic Holdings, adding an estimated $1.16K. The largest seller was Beryl Capital Management, exiting entirely with an estimated $22M sold.
- 1 institutional investor held NEVRO CORP. (NVRO) as of Q2 2025, down from 126 in Q1 2025.
- Funds reported $27.2K of NEVRO CORP. stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new NEVRO CORP. positions in Q2 2025 and 125 closed out, a net change of -125 holders.
- The largest NEVRO CORP. buyer in Q2 2025 was Osaic Holdings, an estimated $1.16K added.
- The largest NEVRO CORP. seller in Q2 2025 was Beryl Capital Management, an estimated $22M sold.
Based on aggregated 13F filings for Q2 2025.